Literature DB >> 21470317

GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity.

P J Verhulst1, A Lintermans, S Janssen, D Loeckx, U Himmelreich, J Buyse, J Tack, I Depoortere.   

Abstract

GPR39, which may function as a Zn(2+) sensor, is a member of the G protein-coupled receptor family that also includes the receptor for the hunger hormone ghrelin. The down-regulation of GPR39 mRNA in adipose tissue of obese type 2 diabetic patients suggests that GPR39 may contribute to the pathogenesis of the disease. The present study aimed to investigate the role of GPR39 in the regulation of energy balance and glucose homeostasis in wild-type (GPR39(+/+) ) and GPR39 knockout mice (GPR39(-/-) ) with obesity-related type 2 diabetes. GPR39 mRNA levels in adipose tissue of fasted GPR39(+/+) mice fed a high-fat diet (HFD) for 30 weeks were reduced and correlated positively with blood glucose levels. Body weight, fat percentage and energy intake were increased in the HFD group but did not differ between both genotypes. Within the HFD group, blood glucose levels were lower in GPR39(-/-) than in GPR39(+/+) mice, despite significant reductions in prandial plasma insulin levels. The latter may not be a result of changes in β-cell hyperplasia because immunohistochemical staining of pancreata of mice on a HFD showed no differences between genotypes. The lower blood glucose levels may involve alterations in insulin sensitivity as revealed by glucose tolerance tests and respiratory quotient measurements that showed a preference of obese GPR39(-/-) mice for the use of carbohydrates as metabolic fuel. The increase in plasma ghrelin levels in GPR39(-/-) mice fed a HFD may contribute to the alterations in glucose homeostasis, whereas changes in gastric emptying or intestinal Zn(2+) absorption are not involved. The results obtained in the present study suggest that GPR39 plays a role in the pathogenesis of obesity-related type 2 diabetes by affecting the regulation of glucose homeostasis.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470317     DOI: 10.1111/j.1365-2826.2011.02132.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  14 in total

1.  Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Authors:  Stefan Peukert; Richard Hughes; Jill Nunez; Guo He; Zhao Yan; Rishi Jain; Luis Llamas; Sarah Luchansky; Adam Carlson; Guiqing Liang; Vidya Kunjathoor; Mike Pietropaolo; Jeffrey Shapiro; Anja Castellana; Xiaoping Wu; Avirup Bose
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

2.  Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Authors:  Seiji Sato; Xi-Ping Huang; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2016-10-17       Impact factor: 4.436

3.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

4.  Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.

Authors:  Markus Boehm; David Hepworth; Paula M Loria; Lisa D Norquay; Kevin J Filipski; Janice E Chin; Kimberly O Cameron; Martin Brenner; Peter Bonnette; Shawn Cabral; Edward Conn; David C Ebner; Denise Gautreau; John Hadcock; Esther C Y Lee; Alan M Mathiowetz; Michelle Morin; Lucy Rogers; Aaron Smith; Maria VanVolkenburg; Philip A Carpino
Journal:  ACS Med Chem Lett       Date:  2013-09-16       Impact factor: 4.345

5.  Rare-variant pathogenicity triage and inclusion of synonymous variants improves analysis of disease associations of orphan G protein-coupled receptors.

Authors:  Ridge Dershem; Raghu P R Metpally; Kirk Jeffreys; Sarathbabu Krishnamurthy; Diane T Smelser; Michal Hershfinkel; David J Carey; Janet D Robishaw; Gerda E Breitwieser
Journal:  J Biol Chem       Date:  2019-10-18       Impact factor: 5.157

6.  Reduced triglyceride secretion in response to an acute dietary fat challenge in obese compared to lean mice.

Authors:  Aki Uchida; Mary C Whitsitt; Trisha Eustaquio; Mikhail N Slipchenko; James F Leary; Ji-Xin Cheng; Kimberly K Buhman
Journal:  Front Physiol       Date:  2012-02-24       Impact factor: 4.566

7.  Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.

Authors:  Ola Fjellström; Niklas Larsson; Shin-Ichiro Yasuda; Takuma Tsuchida; Takahiro Oguma; Anna Marley; Charlotte Wennberg-Huldt; Daniel Hovdal; Hajime Fukuda; Yukimi Yoneyama; Kazuyo Sasaki; Anders Johansson; Sara Lundqvist; Johan Brengdahl; Richard J Isaacs; Daniel Brown; Stefan Geschwindner; Lambertus Benthem; Claire Priest; Andrew Turnbull
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

8.  Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk-an exploratory study.

Authors:  Ken Declerck; Sylvie Remy; Christine Wohlfahrt-Veje; Katharina M Main; Guy Van Camp; Greet Schoeters; Wim Vanden Berghe; Helle R Andersen
Journal:  Clin Epigenetics       Date:  2017-04-05       Impact factor: 6.551

9.  Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice.

Authors:  Lana Leung; Jonathan Kang; Esa Rayyan; Ashesh Bhakta; Brennan Barrett; David Larsen; Ryan Jelinek; Justin Willey; Scott Cochran; Tom L Broderick; Layla Al-Nakkash
Journal:  Diabetes Metab Syndr Obes       Date:  2014-07-21       Impact factor: 3.168

Review 10.  Role of GPR39 in Neurovascular Homeostasis and Disease.

Authors:  Yifan Xu; Anthony P Barnes; Nabil J Alkayed
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.